Burosumab (Anti-FGF23)

Ask supplier a question | View on supplier's website

Burosumab (Anti-FGF23) is a neutralizing antibody, targeting human fibroblast growth factor 23 (FGF23). It can be used for the research of X-linked hypophosphatemia (XLH) and tumor-induced osteomalacia. MW: 145.5 KD.

Supplier	Selleck Chemicals
Product #	A2499
Sku #	A2499-1mg*25
Pricing	1mg*25, $2370.00

Feedback